IMMUNO-ONCOLOGY: RAPIDLY DEFINING NEW THERAPEUTIC STANDARDS
At H-Immune, we strongly believe a stimulated immune system to be the greatest patient asset in fighting cancer. Although tumor cells use multiple mechanisms to evade the body’s immune response, we believe implementation of an immunotherapeutic approach is the key to elimination of these tumor cells from the body.
With an ambitious game changing agenda, H-Immune is committed to making a positive contribution to the medical community by developing novel immune-based therapeutics to help patients leverage their own immune defense to fight the disease of cancer.
To achieve this goal, it is our intension to implement the latest knowledge of immunological pathways into breakthrough therapeutics, driven by our proprietary fully human Ab-platform.